The Valley Desk

NCT01538095 · Interventional trial

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Overall registry status Completed

Phase 1

Conditions Central Nervous System Neoplasm, Solid Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov